What Is the Treatment of Penile Cancer with Distant Metastasis (M1)?

Clinical Scenario

This protocol applies to patients with distant metastatic penile squamous cell carcinoma (M1) — disease confirmed to have spread to distant sites beyond regional nodes.

First-line palliative systemic therapy is the cornerstone of management in this stage, and patient enrolment in structured research programmes forms a recognised part of the care pathway.

Treatment Approach

First-Line Protocol

For eligible patients with M1 disease, the treatment pathway includes the option of enrolment in clinical trials — among them experimental therapies offered within early-phase or tumour-agnostic trial formats. The complete regimen, specific eligibility criteria, and full sequencing are available in the structured protocol below.

Instant Access to Structured Evidence-Based Regimens

References

Offer patients with distant metastatic disease platinum-based chemotherapy as the preferred approach to first-line palliative systemic therapy.

Offer patients with progressive disease under platinum chemotherapy the opportunity to enrol in clinical trials, including experimental therapies within phase I or basket trials.

View source ↗